Europe In-vitro Toxicology Testing Market Size & Outlook

The in-vitro toxicology testing market in Europe is expected to reach a projected revenue of US$ 19,962.3 million by 2030. A compound annual growth rate of 10.5% is expected of Europe in-vitro toxicology testing market from 2024 to 2030.
Revenue, 2023 (US$M)
$9,919.1
Forecast, 2030 (US$M)
$19,962.3
CAGR, 2024 - 2030
10.5%
Report Coverage
Europe

Europe in-vitro toxicology testing market, 2018-2030 (US$M)

Europe

Europe in-vitro toxicology testing market highlights

  • The Europe in-vitro toxicology testing market generated a revenue of USD 9,919.1 million in 2023.
  • The market is expected to grow at a CAGR of 10.5% from 2024 to 2030.
  • In terms of segment, pharmaceutical industry was the largest revenue generating end user in 2023.
  • Diagnostics is the most lucrative end user segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 9,919.1 million
Market revenue in 2030USD 19,962.3 million
Growth rate10.5% (CAGR from 2023 to 2030)
Largest segmentPharmaceutical industry
Fastest growing segmentDiagnostics
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry
Key market players worldwideCharles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc


Other key industry trends

  • In terms of revenue, Europe region accounted for 32.0% of the global in-vitro toxicology testing market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • North America is the fastest growing regional market and is projected to reach USD 32,265.4 million by 2030.

Pharmaceutical industry was the largest segment with a revenue share of 42.56% in 2023. Horizon Databook has segmented the Europe in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.


The Europe market is expected to grow at a significant rate owing to the support from government and nongovernment organizations for R&D of novel therapeutics. Launch of new initiatives and programs in the country to explore alternative approaches for chemical safety evaluation is anticipated to drive the growth of companies operating in this space.

Furthermore, the European Society of Toxicology In Vitro helps in establishing connections between organizations and individuals with interests in in vitro toxicology applications across Europe. This is expected to help boost activities associated with in vitro toxicology testing in the country.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In-vitro Toxicology Testing Market Companies

Name Profile # Employees HQ Website

Europe in-vitro toxicology testing market size, by country, 2018-2030 (US$M)

Europe In-vitro Toxicology Testing Market Outlook Share, 2023 & 2030 (US$M)

Europe in-vitro toxicology testing market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more